VERA icon

Vera Therapeutics

160 hedge funds and large institutions have $2.21B invested in Vera Therapeutics in 2024 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 51 increasing their positions, 32 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

2.44% more ownership

Funds ownership: 95.3%97.73% (+2.4%)

62% less call options, than puts

Call options by funds: $6.1M | Put options by funds: $16M

Holders
160
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.1M
Puts
$16M
Net Calls
Net Calls Change

Top Buyers

1 +$227M
2 +$103M
3 +$52.1M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$36.1M
5
SC
Samlyn Capital
New York
+$27.8M

Top Sellers

1 -$98.5M
2 -$91.6M
3 -$67.3M
4
O
OrbiMed
New York
-$36.3M
5
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$32.7M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$24.1M
27
$21.8M
28
$20.7M
29
$20.3M
30
$19.3M
31
$18.8M
32
$16.5M
33
$16.1M
34
$15.5M
35
$15.2M
36
$14.7M
37
$14.6M
38
$14.5M
39
$13.3M
40
$11.7M
41
$11.1M
42
$10.4M
43
$9.73M
44
$8.63M
45
$7.54M
46
$6.7M
47
$6.64M
48
$6.58M
49
$6.33M
50
$6.1M